TR
3SBio Inc.
TRSBF · OTC
$2.15 +0.00% (+$0.00)
Market Cap ¥36.0B
P/E Ratio 4.36x
Div. Yield 1.48%
ROE 38.21%
Bulios Fair Price
$3
39.5% upside
Trenutna cena
$2.15
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TRSBF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
97 /100
Cheap EV/EBITDA 2.44x
P/S 2.09x
P/B 1.32x
Growth
100 /100
Growing Rev. growth 35.96%
FCF growth 96.31%
Book val. growth 28.06%
Profitability
100 /100
Strong Net margin 47.93%
Op. margin 59.66%
FCF margin 52.95%
Quality
91 /100
Excellent ROE 38.21%
ROA 22.78%
Asset turnover 0.48x
Debt
100 /100
Low Current ratio 5.13x
Int. coverage 138.22x
Net debt/EBITDA -0.90x
Stability
31 /100
Unstable Rev. volatility 42.76%
EPS volatility 166.61%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRSBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jing Lou
Employees
6,109
Headquarters
Shenyang
Prihajajoči dogodki
30 MAR.
Earnings
Upcoming earnings report